Heart Transplant Research Today is a free monthly online journal that collates and summarizes the latest research about Heart Transplant, including details on risks, prognosis, procedure, surgery, organ donation.

Volume 3 (2007), Issue 6 (June)

1. Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.
   Am Heart J, 153(6): 932-40. [Abstract] [Full-text]
2. The relationship of anti-MICA antibodies and MICA expression with heart allograft rejection.
   Am J Transplant, 7(7): 1842-8. [Abstract] [Full-text]
3. Enhanced cardiac allograft survival by Vav1-Rac signaling blockade in a mouse model.
   Transpl Immunol, 18(1): 53-61. [Abstract] [Full-text]
4. Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation.
   Transpl Immunol, 18(1): 13-21. [Abstract] [Full-text]
5. Rosiglitazone suppresses cyclosporin-induced chronic transplant dysfunction and prolongs survival of rat cardiac allografts.
   Transplantation, 83(12): 1602-10. [Abstract] [Full-text]
6. Organ-specific differences in the function of MCP-1 and CXCR3 during cardiac and skin allograft rejection.
   Transplantation, 83(12): 1595-601. [Abstract] [Full-text]
7. End-stage renal disease due to polyomavirus in a cardiac transplant patient.
   Nat Clin Pract Nephrol, 3(7): 393-6. [Abstract] [Full-text]
8. The subepicardial microcirculation in heterotopically transplanted mouse hearts: an intravital multifluorescence microscopy study.
   J Thorac Cardiovasc Surg, 134(1): 210-7, 217.e1. [Abstract] [Full-text]

© 2005-2008 Heart Transplant Research Today. All Rights Reserved.